263 related articles for article (PubMed ID: 32657345)
21. Low dose radiation risks for women surviving the a-bombs in Japan: generalized additive model.
Dropkin G
Environ Health; 2016 Nov; 15(1):112. PubMed ID: 27881134
[TBL] [Abstract][Full Text] [Related]
22. Reanalysis of cancer mortality in Japanese A-bomb survivors exposed to low doses of radiation: bootstrap and simulation methods.
Dropkin G
Environ Health; 2009 Dec; 8():56. PubMed ID: 20003238
[TBL] [Abstract][Full Text] [Related]
23. Curvilinearity in the dose-response curve for cancer in Japanese atomic bomb survivors.
Little MP; Muirhead CR
Environ Health Perspect; 1997 Dec; 105 Suppl 6(Suppl 6):1505-9. PubMed ID: 9467073
[TBL] [Abstract][Full Text] [Related]
24. Ionizing radiation and cancer risk: evidence from epidemiology.
Ron E
Radiat Res; 1998 Nov; 150(5 Suppl):S30-41. PubMed ID: 9806607
[TBL] [Abstract][Full Text] [Related]
25. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
Little MP
Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
[TBL] [Abstract][Full Text] [Related]
26. The scientific basis for the use of the linear no-threshold (LNT) model at low doses and dose rates in radiological protection.
Laurier D; Billarand Y; Klokov D; Leuraud K
J Radiol Prot; 2023 Jun; 43(2):. PubMed ID: 37339605
[TBL] [Abstract][Full Text] [Related]
27. [How to understand low dose risks].
Nakamura N
Igaku Butsuri; 2012; 32(4):202-8. PubMed ID: 24568026
[TBL] [Abstract][Full Text] [Related]
28. Methodological improvements to meta-analysis of low dose rate studies and derivation of dose and dose-rate effectiveness factors.
Little MP; Pawel DJ; Abalo K; Hauptmann M
Radiat Environ Biophys; 2021 Aug; 60(3):485-491. PubMed ID: 34218328
[TBL] [Abstract][Full Text] [Related]
29. Ionizing radiation and kidney cancer among Japanese atomic bomb survivors.
Richardson DB; Hamra G
Radiat Res; 2010 Jun; 173(6):837-42. PubMed ID: 20518663
[TBL] [Abstract][Full Text] [Related]
30. Cancer after exposure to radiation in the course of treatment for benign and malignant disease.
Little MP
Lancet Oncol; 2001 Apr; 2(4):212-20. PubMed ID: 11905766
[TBL] [Abstract][Full Text] [Related]
31. Age at exposure and attained age variations of cancer risk in the Japanese A-bomb and radiotherapy cohorts.
Schneider U; Walsh L
Med Phys; 2015 Aug; 42(8):4755-61. PubMed ID: 26233203
[TBL] [Abstract][Full Text] [Related]
32. Cancer risks from medical radiation.
Ron E
Health Phys; 2003 Jul; 85(1):47-59. PubMed ID: 12852471
[TBL] [Abstract][Full Text] [Related]
33. On the biological effects of cosmic rays: epidemiological studies.
Signorini C; Conforto AM
Nuovo Cimento C; 1992; 15(5):565-73. PubMed ID: 11541732
[TBL] [Abstract][Full Text] [Related]
34. Progress in low dose health risk research: Novel effects and new concepts in low dose radiobiology.
Averbeck D; Salomaa S; Bouffler S; Ottolenghi A; Smyth V; Sabatier L
Mutat Res Rev Mutat Res; 2018; 776():46-69. PubMed ID: 29807577
[TBL] [Abstract][Full Text] [Related]
35. Fitting the Armitage-Doll model to radiation-exposed cohorts and implications for population cancer risks.
Little MP; Hawkins MM; Charles MW; Hildreth NG
Radiat Res; 1992 Nov; 132(2):207-21. PubMed ID: 1438703
[TBL] [Abstract][Full Text] [Related]
36. Evidence for curvilinearity in the cancer incidence dose-response in the Japanese atomic bomb survivors.
Little MP; Muirhead CR
Int J Radiat Biol; 1996 Jul; 70(1):83-94. PubMed ID: 8691040
[TBL] [Abstract][Full Text] [Related]
37. Risk of solid cancer in low dose-rate radiation epidemiological studies and the dose-rate effectiveness factor.
Shore R; Walsh L; Azizova T; Rühm W
Int J Radiat Biol; 2017 Oct; 93(10):1064-1078. PubMed ID: 28421857
[TBL] [Abstract][Full Text] [Related]
38. Recent Epidemiologic Studies and the Linear No-Threshold Model For Radiation Protection-Considerations Regarding NCRP Commentary 27.
Shore RE; Beck HL; Boice JD; Caffrey EA; Davis S; Grogan HA; Mettler FA; Preston RJ; Till JE; Wakeford R; Walsh L; Dauer LT
Health Phys; 2019 Feb; 116(2):235-246. PubMed ID: 30585971
[TBL] [Abstract][Full Text] [Related]
39. Risk assessment for cancer induction after low- and high-LET therapeutic irradiation.
Engels H; Menzel HG; Pihet P; Wambersie A
Strahlenther Onkol; 1999 Jun; 175 Suppl 2():47-51. PubMed ID: 10394397
[TBL] [Abstract][Full Text] [Related]
40. Special radiobiological features of second cancer risk after particle radiotherapy.
Trott KR
Phys Med; 2017 Oct; 42():221-227. PubMed ID: 29103987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
